What is it about?
Lung cancer still remains diagnosed at a late stage although we have novel diagnostic techniques at our disposal. However; for metastatic disease we have novel therapies based on pharmacogenomics. Tumor heterogenity provides us different treatments. There are several reasons for carcinogenesis; fibrosis and scar tissue provides an environment that induces malignancy. In the current review we will try and elucidate the pathways involved from scar tissue to carcinogenesis.
Featured Image
Read the Original
This page is a summary of: Scar tissue to lung cancer; pathways and treatment, Journal of Cancer, January 2019, Ivyspring International Publisher,
DOI: 10.7150/jca.30300.
You can read the full text:
Contributors
The following have contributed to this page